IP Verse

Galenicum Health Slu patent opposition analysis

Law FirmOpposition Filing Analysis

The comprehensive analysis of Galenicum Health Slu opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Galenicum Health Slu

Stay updated with the latest patent oppositions filed by Galenicum Health Slu

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3090730
Novel Pharmaceutical CompositionNOVARTISJan 9, 2025GALENICUM HEALTH SLU
EP2395968
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 16, 2024GALENICUM HEALTH SLU
EP3270909
Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular RiskESPERION THERAPEUTICSJul 31, 2024GALENICUM HEALTH SLU
EP3634463
Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALSJun 27, 2024GALENICUM HEALTH SLU
EP3810201
Gip/Glp1 Agonist CompositionsELI LILLYMar 7, 2024GALENICUM HEALTH SLU
EP2508188
Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol HydrateASTRAZENECAFeb 9, 2024GALENICUM HEALTH SLU
EP2482812
Therapeutic Uses Of Pharmaceutical CompositionsBOEHRINGER INGELHEIMOct 11, 2023GALENICUM
EP3191461
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-BenzoxazolePFIZERAug 3, 2022GALENICUM HEALTH SLU
EP3431475
Solid Forms Of A Selective Cdk4/6 InhibitorPFIZERJan 7, 2022GALENICUM HEALTH SLU
EP2797581
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneCELGENEFeb 8, 2021GALENICUM HEALTH SLU

Top clients of Galenicum Health Slu

Top companies who are the clients of Galenicum Health Slu

CompanyTotal
GALENICUM HEALTH SLU18
GALENICUM1